SCHEMBL17448005

SCHEMBL17448005

NC(=O)c1c(C2CCc3ccccc3C2)nn(-c2cccc([N+](=O)[O-])c2)c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ MAPT P10636 8/20 0.44
▸ MAPK14 Q16539 1/20 0.43
▸ HPGD P15428 4/20 0.41
▸ GFER P55789 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ PDE4B Q07343 2/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HTT P42858 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17447940 0.86 RIPK2 (0.40) SMN1; SMN2MAPK14CYP1A2CYP3A4CYP2C19
SCHEMBL17447961 0.83 RAB9A (0.46) RAB9ANPC1SMN1; SMN2MAPTMAPK14
SCHEMBL17447808 0.79 BTK (0.39) RIPK2
SCHEMBL17448035 0.74 RAB9A (0.39) RAB9AMEN1KMT2APDE4BPDE4D
SCHEMBL8359793 0.69 MAPT (0.59) RAB9ANPC1SMN1; SMN2MAPTMAPK14
SCHEMBL17447927 0.69 LMNA (0.36) SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL17447789 0.67 MTNR1A (0.34) —
SCHEMBL17448039 0.67 MTNR1A (0.32) —
SCHEMBL28389945 0.67 MTNR1A (0.34) —
SCHEMBL17447925 0.67 PARP1 (0.42) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106687446-B 5-amino-4-carbamoyl-pyrazole compounds as selective and irreversible kinase inhibitors of T790M/WT-EGFR and uses thereof 百济神州(北京)生物科技有限公司 2020-04-28 — — CN disclosed
WO-2016008411-A1 5-AMINO-4-CARBAMOYL-PYRAZOLE COMPOUNDS AS SELECTIVE AND IRREVERSIBLE T790M OVER WT-EGFR KINASE INHIBITORS AND USE THEREOF BEIGENE, LTD. (KY) 2016-01-21 — — WO disclosed
Send feedback